- Home
- ZD vs MYGN Comparison
ZD vs MYGN Comparison
Compare ZD & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZD | MYGN |
|---|---|---|
| Founded | 1995 | 1991 |
| Country | United States | United States |
| Employees | N/A | 2700 |
| Industry | Advertising | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 396.0M |
| IPO Year | 1999 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ZD | MYGN |
|---|---|---|
| Price | $57.67 | $3.86 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $39.71 | $7.64 |
| AVG Volume (30 Days) | 523.8K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 17.49 | N/A |
| Revenue | ★ $1,364,028,000.00 | $771,400,000.00 |
| Revenue This Year | N/A | $6.86 |
| Revenue Next Year | $2.16 | $5.45 |
| P/E Ratio | $3.38 | ★ N/A |
| Revenue Growth | N/A | ★ 2.33 |
| 52 Week Low | $22.45 | $2.74 |
| 52 Week High | $60.48 | $8.59 |
Technical Indicators
Market Signals| Indicator | ZD | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 62.73 |
| Support Level | $50.59 | $2.89 |
| Resistance Level | $57.48 | $5.42 |
| Average True Range (ATR) | 1.60 | 0.24 |
| MACD | 0.15 | 0.16 |
| Stochastic Oscillator | 44.91 | 89.20 |
Price Performance
Historical ComparisonAbout ZD Ziff Davis Inc.
Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.